{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:24:44Z","timestamp":1777793084711,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.thromres.2024.109110","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:04:15Z","timestamp":1723010655000},"page":"109110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A long term outcomes analysis of severe haemophilia A boys receiving 4\u00a0years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS)"],"prefix":"10.1016","volume":"241","author":[{"given":"Wanru","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koon-Hung","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109110_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/hae.12394","article-title":"Joint disease status of severe and moderate haemophilia patients at the Beijing Children\u2019s Hospital: early onset and rapid increasing severity of arthropathy in 90% of patients by 6 years of age","volume":"20","author":"Wu","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2516.2008.01821.x","article-title":"Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities","volume":"14","author":"Poon","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2516.2010.02348.x","article-title":"Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China","volume":"17","author":"Wu","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/17474086.2017.1386096","article-title":"The benefit of low dose prophylaxis in the treatment of hemophilia: a focus on China","volume":"10","author":"Wu","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.thromres.2024.109110_bb0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/hae.12838","article-title":"A randomized study of very low-dose factor VIII prophylaxis in severe haemophilia - a success story from a resource limited country","volume":"22","author":"Verma","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/hae.12853","article-title":"Low-dose prophylaxis for severe haemophilia: a little goes a long way","volume":"22","author":"Fischer","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12552","article-title":"Significant reduction in hemarthrosis in boys with severe hemophilia A: the China hemophilia individualized low-dose secondary prophylaxis study","volume":"5","author":"Wu","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109110_bb0040","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109110_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13244-021-01043-0","article-title":"A semiquantitative color Doppler ultrasound scoring system for evaluation of synovitis in joints of patients with blood-induced arthropathy","volume":"12","author":"Zhang","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1016\/j.thromres.2024.109110_bb0050","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-2516.2009.02016.x","article-title":"Refinement of a sonographic protocol for assessment of haemophilic arthropathy","volume":"15","author":"Keshava","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2516.2006.01414.x","article-title":"Sonography for assessment of haemophilic arthropathy in children: a systematic protocol","volume":"13","author":"Zukotynski","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0060","article-title":"Sonography for assessment of elbows in hemophilic children: a systematic protocol","volume":"2","author":"Xavier","year":"2012","journal-title":"OMICS International"},{"key":"10.1016\/j.thromres.2024.109110_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/hae.12489","article-title":"Validation of the Chinese version of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (the CHO-KLAT)","volume":"20","author":"Wu","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/hae.14635","article-title":"Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A","author":"Huang","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109110_bb0075","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S2352-3026(18)30048-6","article-title":"Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort","volume":"5","author":"Feldman","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2024.109110_bb0080","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2012-12-470898","article-title":"Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s","volume":"122","author":"Fischer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.109110_bb0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/jth.12113","article-title":"Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study","volume":"11","author":"Hilliard","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109110_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/hae.13349","article-title":"Describing the quality of life of boys with haemophilia in China: results of a multicentre study using the CHO-KLAT","volume":"24","author":"Tang","year":"2018","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:03:26Z","timestamp":1725055406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":18,"alternative-id":["S0049384824002421"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109110","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A long term outcomes analysis of severe haemophilia A boys receiving 4\u00a0years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109110"}}